Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome

Human Genetics

Volumn 133, Issue 1, 2014, Pages 59-67

  Pastori, Chiara ^a   Peschansky, Veronica J ^a   Barbouth, Deborah ^a   Mehta, Arpit ^a   Silva, Jose P ^a   Wahlestedt, Claes ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FMR5 PROTEIN; FMR6 PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; LONG UNTRANSLATED RNA; RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; ATAXIA; BRAIN REGION; BRAIN TISSUE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; FRAGILE X SYNDROME; FRAGILE X TREMOR AND ATAXIA SYNDROME; GENE AMPLIFICATION; GENE CONTROL; GENE LOCUS; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN TISSUE; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREMOR;

EID: 84891870087     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-013-1356-6     Document Type: Article

References (52)

1. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A et al (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in Fragile X study-preliminary data. Am J Med Genet 83:322-325 (Pubitemid 29162637)
2. Antar LN, Dictenberg JB, Plociniak M, Afroz R, Bassell GJ (2005) Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Genes Brain Behav 4:350-359 (Pubitemid 41192447)
3. Banfai B, Jia H, Khatun J, Wood E, Risk B, Gundling WE Jr, Kundaje A, Gunawardena HP, Yu Y, Xie L et al (2012) Long noncoding RNAs are rarely translated in two human cell lines. Genome Res 22:1646-1657
4. Brown V, Small K, Lakkis L, Feng Y, Gunter C, Wilkinson KD, Warren ST (1998) Purified recombinant FMRp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J Biol Chem 273:15521-15527 (Pubitemid 28298162)
5. Chen L, Toth M (2001) Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043-1050 (Pubitemid 32289314)
6. Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, Long J, Stern D, Tammana H, Helt G et al (2005) Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 308:1149-1154 (Pubitemid 40696429)
7. Cho DH, Thienes CP, Mahoney SE, Analau E, Filippova GN, Tapscott SJ (2005) Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell 20:483-489 (Pubitemid 41572304)
8. Coffee B, Zhang F, Warren ST, Reines D (1999) Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 22:98-101 (Pubitemid 29214814)
9. Coffee B, Zhang F, Ceman S, Warren ST, Reines D (2002) Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet 71:923-932 (Pubitemid 135750522)
10. de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA (2002) DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 62:2695-2698 (Pubitemid 34462754)
11. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37(9):e67
12. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F et al (2012) Landscape of transcription in human cells. Nature 489:101-108
13. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, Tada T, Dolan BM, Sharp PA, Sheng M (2010) Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65:373-384
14. Faghihi MA, Wahlestedt C (2009) Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 10:637-643
15. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G 3rd, Kenny PJ, Wahlestedt C (2008) Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 14:723-730
16. Fisch GS, Hao HK, Bakker C, Oostra BA (1999) Learning and memory in the FMR1 knockout mouse. Am J Med Genet 84:277-282 (Pubitemid 29206983)
17. Garcia-Arocena D, Hagerman PJ (2010) Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 19:R83-R89
18. Geer LY, Domrachev M, Lipman DJ, Bryant SH (2002) CDART: protein homology by domain architecture. Genome Res 12:1619-1623 (Pubitemid 35175101)
19. Gheldof N, Tabuchi TM, Dekker J (2006) The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications. Proc Natl Acad Sci U S A 103:12463-12468 (Pubitemid 44267282)
20. Godfraind JM, Reyniers E, De Boulle K, D'Hooge R, De Deyn PP, Bakker CE, Oostra BA, Kooy RF, Willems PJ (1996) Long-term potentiation in the hippocampus of fragile X knockout mice. Am J Med Genet 64:246-251
21. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130 (Pubitemid 32634862)
22. Han J, Kim D, Morris KV (2007) Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci U S A 104:12422-12427 (Pubitemid 47206153)
23. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD (1991) Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41:289-294
24. Hornstra IK, Nelson DL, Warren ST, Yang TP (1993) High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet 2:1659-1665 (Pubitemid 23358685)
25. Huang T, Li LY, Shen Y, Qin XB, Pang ZL, Wu GY (1996) Alternative splicing of the FMR1 gene in human fetal brain neurons. Am J Med Genet 64:252-255
26. Irwin SA, Galvez R, Greenough WT (2000) Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex 10:1038-1044
27. Kenneson A, Zhang F, Hagedorn CH, Warren ST (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449-1454 (Pubitemid 32684886)
28. Khalil AM, Faghihi MA, Modarresi F, Brothers SP, Wahlestedt C (2008) A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One 3:e1486 (Pubitemid 351803432)
29. Kumari D, Usdin K (2010) The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum Mol Genet 19:4634-4642
30. Kurokawa R (2011) Promoter-associated long noncoding RNAs repress transcription through a RNA binding protein TLS. Adv Exp Med Biol 722:196-208
31. Ladd PD, Smith LE, Rabaia NA, Moore JM, Georges SA, Hansen RS, Hagerman RJ, Tassone F, Tapscott SJ, Filippova GN (2007) An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet 16:3174-3187 (Pubitemid 350131334)
32. Lee JT (2012) Epigenetic regulation by long noncoding RNAs. Science 338:1435-1439
33. Lopez Castel A, Cleary JD, Pearson CE (2010) Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol 11:165-170
34. Martianov I, Ramadass A, Serra Barros A, Chow N, Akoulitchev A (2007) Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445:666-670 (Pubitemid 46232888)
35. Mattick JS (2005) The functional genomics of noncoding RNA. Science 309:1527-1528 (Pubitemid 41266470)
36. Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, Tassone F, Neitzel K, Stackhouse T, Hagerman RJ (1999) Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 83:268-279 (Pubitemid 29162627)
37. Mirkin SM (2007) Expandable DNA repeats and human disease. Nature 447:932-940 (Pubitemid 46975760)
38. Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, Chen G, Weatherspoon MR, Clark HB, Ebner TJ et al (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 38:758-769 (Pubitemid 43980596)
39. O'Donnell WT, Warren ST (2002) A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 25:315-338 (Pubitemid 34748020)
40. Olivarius S, Plessy C, Carninci P (2009) High-throughput verification of transcriptional starting sites by Deep-RACE. Biotechniques 46:130-132
41. Pastori C, Wahlestedt C (2012) Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol 9:860-870
42. Reis EM, Verjovski-Almeida S (2012) Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet 3:32
43. Shi Y, Alpatov R, Wagner U, Nakamoto-Kinoshita M, Ye Z, Luu Y, Armache KJ, Simon MD, Stuetzer A, Greer EL et al (2012) The fragile X mental retardation protein FMRP plays a role in the DNA damage response. Faseb J 26:88.1
44. Sittler A, Devys D, Weber C, Mandel JL (1996) Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of FMR1 protein isoforms. Hum Mol Genet 5:95-102 (Pubitemid 26018279)
45. Song X, Wang X, Arai S, Kurokawa R (2012) Promoter-associated noncoding RNA from the CCND1 promoter. Methods Mol Biol 809:609-622
46. Stafstrom CE, Hagerman PJ, Pessah IN (2012) Pathophysiology of epilepsy in autism spectrum disorders. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper's basic mechanisms of the epilepsies, Bethesda MD
47. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST (1992) DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1:397-400
48. Tan H, Li H, Jin P (2009) RNA-mediated pathogenesis in fragile X-associated disorders. Neurosci Lett 466:103-108
49. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6-15 (Pubitemid 30481464)
50. The Dutch-Belgian Fragile X Consortium (1994) FMR1 knockout mice: a model to study fragile X mental retardation. Cell 78:23-33
51. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A 94:5395-5400 (Pubitemid 27214794)
52. Yan BX, Ma JX (2012) Promoter-associated RNAs and promoter-targeted RNAs. CMLS 69:2833-2842